Consumer HealthTech Stocks
Consumer HealthTech firms develop and distribute medical hardware, digital diagnostics, and self-care therapeutics directly to end-users or through employer-sponsored health accounts. These businesses operate at the intersection of regulated healthcare and retail commerce, often utilizing recurring revenue models driven by consumable components or subscription-based monitoring services.
As of Oct 23, 2026, Consumer HealthTech has 21 US-listed companies worth $347B combined. The median member moved -1.1% over the past week; LGMK led at +30.0% and ALUR trailed at -96.6%.
Companies in Consumer HealthTech
- ABT – Abbott Laboratories, $177B
- GALDY – GALDERMA GROUP AG, $54B
- HLN – Haleon plc, $45.6B
- KVUE – Kenvue Inc., $37.6B
- VTRS – Viatris Inc, $21.2B
- HQY – HealthEquity Inc, $8B
- GDRX – Goodrx Holdings Inc, $1.1B
- ENHA – Enhanced Group Inc., $491M
- MCTA – Charming Medical Limited Class A Ordinary Shares, $446M
- PRE – Prenetics Global Ltd, $361M
- OSUR – OraSure Technologies Inc, $260M
- NAGE – Niagen Bioscience, Inc., $214M
- LFMD – LifeMD Inc, $109M
- SLSN – Solesence, Inc. Common Stock, $63.6M
- AYTU – Aytu BioScience Inc, $21.3M
- BON – Bon Natural Life Ltd, $9.2M
- MGRX – Mangoceuticals, Inc. Common Stock, $6.4M
- GYGY – Game Your Game, Inc. Common Stock, $5.9M
- LGMK – LogicMark Inc, $989,734
- ALUR – Allurion Technologies, Inc., $342,107
- HLTH – Cue Health Inc